EUVIMEDEUVIMED entdecken
Crossref

Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway

Kongbo Chen, Junwei Chen iD

Chemical Biology & Drug Design · 2026-03 · 107 (3)

DOI: 10.1111/cbdd.70275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 08.03.2026. Verfasst von Kongbo Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Respiratory Medicine, Nanyang Central Hospital (Nanyang Maternal and Child Health Care Hospital), Nanyang, China. Hauptthemen laut MEDLINE: Quinazolines, NF-kappa B, Asthma, Indole Alkaloids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric asthma is a common chronic condition with several pathological features, including airway inflammation, remodeling, and oxidative stress. Rutaecarpine (RUT), a bioactive alkaloid, exhibits therapeutic efficacy against various allergic diseases. However, its roles in asthma and the underlying molecular mechanisms remain elusive. In this study, we established an ovalbumin (OVA)‐induced mouse model of asthma. The results showed that compared with the OVA‐challenged group, treatment with RUT (10 and 20 mg/kg) reduced lung tissue inflammatory scores by 37.5% and 50.0%, respectively. Additionally, RUT suppressed the production of interleukin (IL)‐4, IL‐5, and IL‐13, and decreased the counts of total cells, eosinophils, macrophages, neutrophils, and lymphocytes in bronchoalveolar lavage fluid. Regarding airway remodeling, RUT downregulated the mRNA and protein expression of α‐smooth muscle actin and type I collagen. Furthermore, periodic acid‐Schiff staining showed that RUT ameliorated OVA‐induced mucus hypersecretion. RUT treatment also exhibited a protective effect on OVA‐induced oxidative damage in lung tissues. Mechanistically, RUT suppressed OVA‐induced activation of the nuclear factor‐kappa B (NF‐κB) pathway. Collectively, RUT attenuated inflammation, airway remodeling, and oxidative stress in OVA‐induced asthmatic mice by inhibiting the NF‐κB pathway, highlighting its potential as an adjunct therapy for pediatric asthma and providing a theoretical basis for future clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinazolinesNF-kappa BAsthmaIndole AlkaloidsSignal TransductionAnimalsOvalbuminMiceQuinazolinonesOxidative StressAirway RemodelingLungMice, Inbred BALB CDisease Models, AnimalFemaleCytokinesBronchoalveolar Lavage Fluid

Stichwörter der Autor:innen

NF‐κBairway remodelingasthmainflammationoxidative stressrutaecarpine

Substanzen

QuinazolinesrutecarpineNF-kappa BOvalbuminIndole AlkaloidsQuinazolinonesCytokines

Autor:innen und Institutionen

  • Department of Pediatric Respiratory Medicine, Nanyang Central Hospital (Nanyang Maternal and Child Health Care Hospital), Nanyang, China.
  • Department of Pediatrics, Chun'an First People's Hospital, Hangzhou, China.

ORCID-Profile: Junwei Chen

Zitieren

APA

Chen, K., & Chen, J. (2026). Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway. Chemical Biology & Drug Design, 107(3). https://doi.org/10.1111/cbdd.70275

Vancouver

Chen K, Chen J. Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway. Chemical Biology & Drug Design. 2026;107(3). doi:10.1111/cbdd.70275

BibTeX
@article{Chen2026,
  author = {Chen, Kongbo and Chen, Junwei},
  title = {Rutaecarpine Attenuates Ovalbumin‐Induced Asthma in Mice by Regulating the NF ‐ κB Pathway},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {107},
  number = {3},
  doi = {10.1111/cbdd.70275}
}
Kostenlos starten →